Suppr超能文献

颅底累及的嗅神经母细胞瘤、神经内分泌癌和未分化鼻-鼻窦癌的治疗。

Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.

机构信息

Division of Neurosurgery, House Clinic, Los Angeles, CA, USA.

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

出版信息

J Neurooncol. 2020 Dec;150(3):367-375. doi: 10.1007/s11060-020-03537-1. Epub 2020 May 18.

Abstract

INTRODUCTION

Sinonasal tumors that harbor neuroendocrine histologic features include olfactory neuroblastoma (previously known as esthesioneuroblastoma), sinonasal neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma. These tumors represent a diverse spectrum of clinical behavior and as such require histology-specific management. Herein, we review the management of these sinonasal tumors with neuroendocrine features and discuss fundamentals of multi-modality care for each histology. An emphasis is placed on olfactory neuroblastomas, given their relative frequency and skullbase origin.

METHODS

A comprehensive literature review on contemporary management of olfactory neuroblastoma, sinonasal neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma was performed.

RESULTS

Management of sinonasal tumors with neuroendocrine features can include surgical resection, radiation therapy, and/or chemotherapy. Due to their site of origin, these tumors can frequently involve the skullbase, which can require site-specific care. The optimal treatment modalities and the sequence in which they are performed are largely dependent on histology. In most cases, olfactory neuroblastoma is best managed with surgical resection followed by radiation therapy. Sinonasal neuroendocrine carcinomas represent a variety of histologic phenotypes (carcinoid, atypical carcinoid, small cell, and large cell), which determine the optimal treatment modality. Finally, sinonasal undifferentiated carcinoma is likely best managed by induction chemotherapy with subsequent therapy dictated by the initial response.

CONCLUSIONS

A team approach to multi-modality care is essential in the treatment of olfactory neuroblastoma, sinonasal neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma. Early biopsy, histologic diagnosis, and comprehensive imaging are critical to determining the appropriate management paradigm.

摘要

简介

具有神经内分泌组织学特征的鼻腔鼻窦肿瘤包括嗅神经母细胞瘤(以前称为嗅神经母细胞瘤)、鼻腔鼻窦神经内分泌癌和鼻腔鼻窦未分化癌。这些肿瘤代表了一系列不同的临床行为,因此需要进行特定于组织学的管理。在此,我们回顾了具有神经内分泌特征的鼻腔鼻窦肿瘤的治疗方法,并讨论了每种组织学的多模式治疗的基本原则。由于其相对频率和颅底起源,重点放在嗅神经母细胞瘤上。

方法

对嗅神经母细胞瘤、鼻腔鼻窦神经内分泌癌和鼻腔鼻窦未分化癌的当代治疗进行了全面的文献回顾。

结果

具有神经内分泌特征的鼻腔鼻窦肿瘤的治疗方法可以包括手术切除、放射治疗和/或化疗。由于它们的起源部位,这些肿瘤经常涉及颅底,这可能需要特定于部位的护理。最佳治疗方式以及它们的执行顺序在很大程度上取决于组织学。在大多数情况下,嗅神经母细胞瘤最好通过手术切除加放射治疗来治疗。鼻腔鼻窦神经内分泌癌代表了多种组织学表型(类癌、非典型类癌、小细胞和大细胞),这决定了最佳的治疗方式。最后,鼻腔鼻窦未分化癌可能最好通过诱导化疗加随后根据初始反应进行治疗来治疗。

结论

多模式治疗的团队方法对于嗅神经母细胞瘤、鼻腔鼻窦神经内分泌癌和鼻腔鼻窦未分化癌的治疗至关重要。早期活检、组织学诊断和全面的影像学检查对于确定适当的治疗方案至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验